Brown / Achillion Pharmaceuticals Inc. / Dong-A Pharmaceutical Company Ltd. / Google / 2Achillion Pharmaceuticals Inc. / Trius Therapeutic Inc / NCR / Creative Commons / BioMed Central Ltd. / Int J Pharm / /
Country
Mexico / Guinea / Russia / United States / Korea / China / Spain / India / / /
Event
FDA Phase / Name Change / /
IndustryTerm
nanoparticle drug delivery systems / stock solution / drug delivery devices / Stock solutions / online submission / /
MedicalCondition
M. tuberculosis H37Rv / Comparison Of Two Moxifloxacin Containing Treatment Shortening Regimens In Pulmonary Tuberculosis / TB / M. tuberculosis / active infection / chronic respiratory disease / Mycobacterium tuberculosis H37Rv / methicillin-resistant S. aureus / murine tuberculosis / peripheral neuropathy / clinical mycobacterium tuberculosis / skin structure infections / skin infections / experimental tuberculosis / intracellular infection / resistant M. tuberculosis / XDR-TB / Conclusions Mycobacterium tuberculosis / both hypoglycemia / disease / subcutaneous and pulmonary route / post infection / Mycobacterium tuberculosis / hyperglycemia / Methods Culture M. tuberculosis H37Rv / XDR / infection / Oxazolidinones Background Tuberculosis / Tuberculosis / /
MedicalTreatment
drug delivery system / nanocapsules / antibiotics / chemotherapy / drug delivery systems / drug carriers / /
NaturalFeature
Degnan MT / /
Organization
World Health Organization / United States Food and Drug Administration / Universidad Autónoma de Nuevo Léon / Hopital Universitario / FDA / /
Person
Ravi Kumar / Al Shaal / Sung-Hak Choi / Jorge Castro / /
Superantigen profiles of emm and emm-like typeable and nontypeable pharyngeal streptococcal isolates of South India